Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy (Q46492413)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2005

Language	Label	Description	Also known as
English	Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy	scientific article published in January 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

1 reference

based on heuristic

inferred from title

1

object named as

Lucie Blais

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

author name string

Odile Sheehy

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Jean-Marc St-Hilaire

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Giles Bernier

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Philippe Godfroid

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Jacques J LeLorier

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

23

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

493-503

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological issues in estimating the cost of epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New drugs for epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15896100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200523050-00008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15896100

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46492413&oldid=2207906255"